bazedoxifene has been researched along with Fatty Liver in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, M; Barrera, J; Chambliss, KL; McDonald, JG; Mineo, C; Shaul, PW; Tanigaki, K; Thompson, B | 1 |
1 other study(ies) available for bazedoxifene and Fatty Liver
Article | Year |
---|---|
Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
Topics: Abdominal Fat; Adiposity; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Fatty Liver; Female; Indoles; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Ovariectomy; Selective Estrogen Receptor Modulators; Uterus | 2014 |